StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by WHATTHE1on Oct 08, 2020 7:00pm

437 Views

Post# 31693451

Can it get any better?

Can it get any better? Sweeeeeet! It seems our time has come.

GLTA

"The Respiratory Panel will be a highly accurate PCR-based test for 18 viruses and two respiratory bacteria. It will screen for Influenza A, Influenza B, and RSV, amongst the 18 viruses. Testing for multiple respiratory pathogens will not just rule out SARS-CoV-2 infection, but aid physicians in proper patient diagnosis."

Bullboard Posts

Pro Women’s Hockey League comes to NHL 25 in December